In response to rising consumer complaints, India's drug regulator is set to implement new labelling norms for medicines that prioritise readability and help make informed choices ...

In one of the largest crackdowns on an international pharmaceutical trafficking syndicate, India’s Narcotics Control Bureau (NCB) has arrested eight individuals and triggered enforcement actions ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

As per officials, Ketamelon was the only Level 4 darknet vendor operating in India, a top-tier status based on global darknet ...

The Punjab government has decided to arrest individuals who repeatedly sign surety bonds for those charged under the Narcotic ...

Amit Shah congratulated the Narcotics Control Bureau (NCB) global drug cartel bust in which eight people were arrested. The ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

India's clinical trial industry has surged into the top three globally, driven by regulatory reforms, affordability, vast ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.